Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

The study elucidates the prognostic factors that significantly impact the risk of developing MS symptoms in pwRIS at diagnosis, thereby, enhancing the potential for tailored clinical interventions.

Authors

Institutions

Publication Details

Journal
JAMA Neurology
Published
2025-06-02
DOI
https://doi.org/10.1001/jamaneurol.2025.1481
Citations
15
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
22.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

Jan Lycke, Friederike Held, Alfredo Rodríguez Antigüedad, Mar Tintoré et al.
15 citations
JAMA Neurology
Multiple Sclerosis Research Studies
22.07
article

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

Jan Lycke, Friederike Held, Alfredo Rodríguez Antigüedad, Mar Tintoré, Sabine Schädelin, Sara Llufriú, Luciana Midaglia, Igal Rosenstein, Andreu Vilaseca, Harald Hegen, Jan D. Lünemann, Hayrettin Tumani, María Trojano, Bernhard Hemmer, Eva M. M. Strijbis, Francisco Pérez‐Miralles, Xavier Montalbán, Stefan Bittner, Antonio Sánchez, Sara Eichau, Ángel Pérez Sempere, Jens Kühle, Enric Monreal, Jorge Correale, Roberto Furlan, Robert Hoepner, Nicholas Schwab, Samia Joseph Khoury, Konrad Rejdak, Àlex Rovira, Michael Khalil, Nicolás Fissolo, Sergio Martínez‐Yélamos, Andrew T. Chan, Éric Thouvenot, Joep Killestein, Daniela Galimberti, Frauke Zipp, Luisa María Villar, Gary Álvarez-Bravo, Jelena Drulović, Johanna Oechtering, Elena Colombo, Friedemann Paul, Antonio Garcı́a-Merino, Neus Téllez-Lara, José Enrique-Martínez, Jonas Schaller-Nagengast
article en
15 citations

Abstract

The study elucidates the prognostic factors that significantly impact the risk of developing MS symptoms in pwRIS at diagnosis, thereby, enhancing the potential for tailored clinical interventions.

JAMA NeurologyVol. 82(7)
Universitat de Vic - Universitat Central de Catalunya (ES), University of Bern (CH), Medical University of Lublin (PL), Universitat Autònoma de Barcelona (ES), Centre National de la Recherche Scientifique (FR), Innsbruck Medical University (AT), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), Inserm (FR), University of Basel (CH), University of Milan (IT), Universidad de Alcalá (ES), Universität Innsbruck (AT), Johannes Gutenberg University Mainz (DE), Université de Montpellier (FR), Medical University of Graz (AT), Max Delbrück Center (DE), Universidad de Buenos Aires (AR), University Hospital of Bern (CH), Instituto de Salud Carlos III (ES), Bellvitge University Hospital (ES), University Hospital of Basel (CH), TUM Klinikum (DE), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Hospital Universitari i Politècnic La Fe (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Institut d'Investigació Biomédica de Bellvitge (ES), BioCruces Health research Institute (ES), Hospital Universitario Virgen Macarena (ES), University Medical Center of the Johannes Gutenberg University Mainz (DE), Vall d'Hebron Institut de Recerca (ES), University Hospital Münster (DE), American University of Beirut Medical Center (LB), Amsterdam Neuroscience (NL), Centar za Promociju Nauke (RS), Munich Cluster for Systems Neurology (DE), Institut d'Investigació Biomèdica de Girona (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Hospital Del Mar (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Instituto de Investigación Sanitaria de Santiago (ES), Amsterdam University Medical Centers (NL), University Hospital Ulm (DE), Hospital del Mar Research Institute (ES), Institut de Génomique Fonctionnelle (FR), Hospital Clínico Universitario de Valladolid (ES), Hospital Universitario Ramón y Cajal (ES), University of Rostock (DE), University of Bari Aldo Moro (IT), Technical University of Munich (DE), Université de Nîmes (FR), Universitat de Barcelona (ES), Charité - Universitätsmedizin Berlin (DE), Vrije Universiteit Amsterdam (NL), University of Gothenburg (SE)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, Massachusetts General Hospital, Biogen, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Celgene, F. Hoffmann-La Roche, Hexal AG, American University of Beirut, CSL Behring, University of Victoria, University of Bern, Merck KGaA, TG Therapeutics, Mylan, International Progressive MS Alliance, Inselspital, Universitätsspital Bern, Universitätsmedizin Göttingen, Amsterdam University Medical Centers, Horizon Therapeutics, Multiple Sclerosis Society, European Commission, National Research Foundation, Deutsche Forschungsgemeinschaft, Institut National de la Santé et de la Recherche Médicale, Vrije Universiteit Amsterdam, Bundesministerium für Bildung und Forschung, Centre National de la Recherche Scientifique, Universitat de Barcelona, Universidad de Alcalá, Karl-Franzens-Universität Graz, Medizinische Universität Innsbruck, Medizinische Universität Graz, Universitat Autònoma de Barcelona, Universität Innsbruck, Ipsen, Neuraxpharm, MedDay Pharmaceuticals, Amsterdam Neuroscience, Samsung, EMD Serono, Chugai Pharmaceutical, Sanofi Genzyme, Instituto de Salud Carlos III, NIH Clinical Center, Cilag
Good health and well-being
Openalex Percentile: Top 0%
Multiple Sclerosis Research Studies
22.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.